NasdaqGS - Nasdaq Real Time Price • USD
Hologic, Inc. (HOLX)
At close: May 17 at 4:00 PM EDT
After hours: May 17 at 4:07 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 14 | 14 | 17 | 17 |
| Avg. Estimate | 1.02 | 1.04 | 4.07 | 4.44 |
| Low Estimate | 0.99 | 1.02 | 4.03 | 4.31 |
| High Estimate | 1.04 | 1.06 | 4.11 | 4.55 |
| Year Ago EPS | 0.93 | 0.89 | 3.96 | 4.07 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 16 | 16 |
| Avg. Estimate | 1B | 1B | 4.03B | 4.25B |
| Low Estimate | 993.7M | 989.2M | 4.02B | 4.16B |
| High Estimate | 1.01B | 1.01B | 4.04B | 4.35B |
| Year Ago Sales | -- | 945.3M | 4.03B | 4.03B |
| Sales Growth (year/est) | -- | 5.80% | 0.10% | 5.50% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.89 | 0.84 | 0.95 | 0.98 |
| EPS Actual | 0.93 | 0.89 | 0.98 | 1.03 |
| Difference | 0.04 | 0.05 | 0.03 | 0.05 |
| Surprise % | 4.50% | 6.00% | 3.20% | 5.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.02 | 1.04 | 4.07 | 4.44 |
| 7 Days Ago | 1.02 | 1.04 | 4.07 | 4.43 |
| 30 Days Ago | 1.02 | 1.04 | 4.03 | 4.39 |
| 60 Days Ago | 1.02 | 1.04 | 4.03 | 4.39 |
| 90 Days Ago | 1.02 | 1.04 | 4.03 | 4.39 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | 4 | 6 | 14 | 11 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| CURRENCY IN USD | HOLX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 9.70% | -- | -- | 8.00% |
| Next Qtr. | 16.90% | -- | -- | 12.40% |
| Current Year | 2.80% | -- | -- | 5.60% |
| Next Year | 9.10% | -- | -- | 13.00% |
| Next 5 Years (per annum) | 7.40% | -- | -- | 11.14% |
| Past 5 Years (per annum) | 7.39% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Argus Research: Buy to Buy | 5/9/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 5/3/2024 |
| Reiterates | Needham: Buy to Buy | 5/3/2024 |
| Reiterates | Needham: Buy to Buy | 4/10/2024 |
| Maintains | Evercore ISI Group: In-Line to In-Line | 4/4/2024 |
| Upgrade | Citigroup: Neutral to Buy | 4/3/2024 |
Related Tickers
RGEN Repligen Corporation
171.94
+0.53%
WST West Pharmaceutical Services, Inc.
355.64
+0.43%
COO The Cooper Companies, Inc.
97.31
-0.60%
BAX Baxter International Inc.
35.25
+0.23%
TFX Teleflex Incorporated
217.64
-0.43%
BDX Becton, Dickinson and Company
236.30
-0.14%
XRAY DENTSPLY SIRONA Inc.
28.28
-0.35%
RMD ResMed Inc.
218.57
-0.64%
ALC Alcon Inc.
88.83
-0.26%
ICUI ICU Medical, Inc.
103.99
-2.15%